摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(8-(isobutylamino)imidazo[1,2-a]pyrazin-3-yl)-N-isopropylbenzamide | 1263420-74-1

中文名称
——
中文别名
——
英文名称
4-(8-(isobutylamino)imidazo[1,2-a]pyrazin-3-yl)-N-isopropylbenzamide
英文别名
4-[8-(2-methylpropylamino)imidazo[1,2-a]pyrazin-3-yl]-N-propan-2-ylbenzamide
4-(8-(isobutylamino)imidazo[1,2-a]pyrazin-3-yl)-N-isopropylbenzamide化学式
CAS
1263420-74-1
化学式
C20H25N5O
mdl
——
分子量
351.451
InChiKey
RKBSUAGOGLJWFS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    26
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.35
  • 拓扑面积:
    71.3
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    4-甲氧甲酰苯硼酸频哪醇酯1,1'-双(二苯膦基)二茂铁二氯化钯(II)二氯甲烷复合物sodium carbonateN,N-二异丙基乙胺间氯过氧苯甲酸 、 N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate 、 lithium hydroxide 作用下, 以 四氢呋喃1,4-二氧六环甲醇二氯甲烷 为溶剂, 反应 22.0h, 生成 4-(8-(isobutylamino)imidazo[1,2-a]pyrazin-3-yl)-N-isopropylbenzamide
    参考文献:
    名称:
    Discovery of Imidazo[1,2-b]pyridazine Derivatives: Selective and Orally Available Mps1 (TTK) Kinase Inhibitors Exhibiting Remarkable Antiproliferative Activity
    摘要:
    Monopolar spindle 1 (Mps1) is an attractive oncology target due to its high expression level in cancer cells as well as the correlation of its expression levels with histological grades of cancers. An imidazo[1,2-a]pyrazine 10a was identified during an HTS campaign. Although 10a exhibited good biochemical activity, its moderate cellular as well as antiproliferative activities needed to be improved. The cocrystal structure of an analogue of 10a guided our lead optimization to introduce substituents at the 6-position of the scaffold, giving the 6-aryl substituted 21b which had improved cellular activity but no oral bioavailability in rat. Property-based optimization at the 6-position and a scaffold change led to the discovery of the imidazo[1,2-b]pyridazine-based 27f, an extremely potent (cellular Mps1 IC50 = 0.70 nM, A549 IC50 = 6.0 nM), selective Mps1 inhibitor over 192 kinases, which could be orally administered and was active in vivo. This 27f demonstrated remarkable antiproliferative activity in the nanomolar range against various tissue cancer cell lines.
    DOI:
    10.1021/jm501599u
点击查看最新优质反应信息